Plavix TTP Lawsuits

If you or someone you know has suffered from internal, gastrointestinal or cerebral bleeding or a condition known as Thrombotic Thrombocytopenic Purpora after taking Plavix, you should contact Slater Slater Schulman LLP for a free consultation by filling out the form on this page or by calling us at (800) 251-6990.

Plavix

Slater Slater Schulman LLP is evaluating potential lawsuits for Plavix (Clopidogrel) users throughout the United States who have suffered serious and potentially fatal injuries as a result of  Plavix. You may have a claim if you, or a family member,  were taking Plavix and suffered:

  • Internal bleeding
  • Gastrointestinal bleeding
  • Cerebral bleeding or Hemorrhage
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Death as a result of internal bleeding
  • Ulcers
  • Heart attacks
  • Strokes
What is Plavix? 
Plavix (clopidogrel) is an oral medication manufactured by Bristol-Meyer Squibb and used for the prevention of blood clots and for reducing the risk of heart attacks and strokes.  Approved in 1997, Plavix is the sixth top selling drug in the U.S., with sales totaling $3.8 billion dollars. It is often prescribed in conjunction with low dose aspirin therapy to prevent heart attacks in high-risk patients.

The Adverse Effects of Plavix
Plavix has been linked to serious side effects in patients with a medical history of gastrointestinal bleeding, peptic ulcer disease (PUD), and high cholesterol. While the American College of Cardiology has recommended Plavix as a safe alternative for those who have a gastrointestinal intolerance for aspirin, research indicates that this recommendation may be unfounded. Recent studies show that Plavix patients are more likely to experience gastrointestinal bleeding and other bleeding than what was previously thought.

One study, published in the New England Journal of Medicine, found that patients taking Plavix experience 12 times as many ulcers than patients taking a combination of aspirin with a heartburn drug. More research (including studies by Oscar Benavente, MD, from the University of British Columbia and Dr. Eric Topol and Dr. Deepak Bhatt of the Cleveland Clinic) also indicates that taking Plavix and aspirin together, as prescribed by many doctors, may double the risk of heart attack, stroke, and death in patients with no prior history of heart disease, but who had high cholesterol.

Since Plavix was introduced, the warnings have not sufficiently informed patients or the medical community of the risks associated with the blood thinner.  Another study conducted by the Centers for Disease Control (CDC) and published in the Archives of Internal Medicine found the risk of hemorrhaging among Plavix-aspirin patients was significantly higher than thought. For years, it was thought the Plavix-aspirin combination would cause less bleeding than an alternative blood thinner, Warfarin, or Coumadin.  Compounding the dangers that are now being disclosed is a recent recommendation from the U.S. Food and Drug Administration (FDA).  In 2009, the FDA recommended that the use of  clopidogrel (Plavix), a drug used to prevent blood clot formation, and omeprazole (Prilosec/Prilosec OTC), used to reduce side gastrointestinal side effects, be avoided because omeprazole reduces the effectiveness of clopidogrel. The new recommendations, updated from a January 2009 Early Communication, are based on study results from the manufacturers of Plavix.  Patients at risk of heart attacks or strokes may not get the full protective anti-clotting effect if they are using clopidogrel and omeprazole together. Sanofi-Aventis and Bristol-Myers Squibb, the makers of Plavix, had to update Plavix’s label with details of the studies and have since been conducting follow-up studies to further explore drug interactions with Plavix.  Thus, in many cases people have taken Plavix and put themselves at unnecessary risk for overstated benefits.

Do I have a Plavix Lawsuit?
Slater Slater Schulman LLP is reviewing potential lawsuits for Plavix users throughout the United States who have suffered serious and potentially fatal injuries as a result of Plavix.    These injuries may include internal, gastrointestinal or cerbral bleeding or a condition known as Thrombotic Thrombocytopenic Purpura (TTP).If you or someone you love has taken Plavix and has suffered from one of these serious injuries, you should contact Slater Slater Schulman LLP for a free consultation by filling out the form on this page or by calling us at (800) 251-6990.

Medical disclaimer: Please note that any change in medications should be made only after consulting with your doctor about the risks and benefits of doing so, and should not be based on any information contained in this web site.

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/31047


Follow Us on:

Contact Us

Privacy Policy

Please click here to view our privacy policy.